PRKAA1 and cancer: AMPK activation can inhibit human cancer cells via different mechanisms (10), including p53 activation, mammalian target of rapamycin (mTOR) complex 1 (mTORC1) inhibition, autophagy induction, and degradation of oncogenes (11, 12).